Pharma Journalist -

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) announced that Health Canada has granted approval for COVIFENZ, COVID-19 vaccine,…
Read More...

Shionogi & Co., Ltd. announced that Shionogi has completed the analysis of primary endpointsa), b) in the Phase 2b part of a Phase 2/3 clinical trial of S-217622, an orally…
Read More...

SMi’s 9th Annual Conference Pre-Filled Syringes East Coast Main Conference: April 25 - 26, 2022 | Workshops: April 27, 2022 Sheraton Boston Hotel, Boston, MA, USA…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) 10 mg to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with…
Read More...

New preclinical data demonstrated that tolebrutinib, Sanofi’s investigational oral Bruton’s tyrosine kinase (BTK) inhibitor for the treatment of multiple sclerosis (MS), was the only…
Read More...

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has awarded a contract to Zhejiang Ausun Pharmaceutical CO, LTD of China…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science,…
Read More...

Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Japanese…
Read More...

ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pre- and post-exposure prophylaxis of…
Read More...

SMi Presents the 16th Annual Conference: Parallel Trade 2022 Conference Date: 21st – 22nd  March 2022 Workshop date: 23rd March 2022 Website:  www.parallel-trade.com/ Navigating…
Read More...